Perjeta, which is pertuzumab, represents a crucial advancement in addressing HER2-positive certain types of cancer. This drug works by inhibiting a specific pathway on helps cancer cells proliferate. In contrast to some other HER2-targeted therapies, pertuzumab avoids directly block the HER2 rece